Ranjay Shaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ranjay Shaw has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Ramendra Pratap
Department of Chemistry, University of Delhi, Delhi, 110007, India
20 shared publications Ismail Althagafi
Department of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah, Saudi Arabia-21955
10 shared publicationsShally
Department of Chemistry, University of Delhi, North Campus, Delhi-110007, India
10 shared publications- Amr Elagamy
Department of Chemistry, University of Delhi, Delhi, India
9 shared publications Rahul Panwar
Univ Delhi, Dept Chem, North Campus, Delhi 110007, India
7 shared publications- Pratik Yadav
Department of Chemistry and Biochemistry, University of Notre Dame, IN 46556, USA
5 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (3) , e70400
Design and Synthesis of Novel 1,2,3‐Triazole Conjugates Featuring Hydroxamic Acid and Sulfonamide Moieties: Exploring Dual Pharmacophores for Enhanced Biological Activity
A new series of N ‐hydroxy‐1‐(4‐(aryl sulfonamido)phenyl)‐1 H ‐1,2,3‐triazole‐4‐carboxamide derivatives ( 8a ‐ j ) were synthesized through a concise multistep route integrating three key pharmacophores: the 1,2,3‐triazole core, an aryl sulfonamide moiety, and an N ‐hydroxycarboxamide group. Biological evaluation demonstrated promising antimicrobial potential for several derivatives. Compounds 8f , 8g , and 8i exhibited notable antibacterial activity against both Gram‐positive and Gram‐negative bacteria, whereas most analogues showed weak antifungal activity. In the antimalarial assay, compound 8d emerged as the most potent derivative (IC 50 = 0.84 μg/mL), while compounds 8b , 8e , 8g , and 8h also displayed appreciable activity. Antitubercular evaluation identified compounds 8g and 8i as the most active derivatives against Mycobacterium tuberculosis H37Rv, with MIC values of 62.5 and 50 μg/mL, respectively. The molecular docking study against DNA gyrase (PDB ID: 7FVT) and lanosterol 14α‐demethylase (PDB ID: 5V5Z) as relevant antibacterial and antifungal targets, respectively, showed a similar trend of activity. Computational studies, including molecular docking, MM/GBSA, molecular dynamics simulations, and ADME prediction, supported the structural and pharmacokinetic characteristics of the synthesized compounds, with selected derivatives exhibiting favorable interactions with the c‐KIT kinase active site and generally acceptable drug‐like properties. Overall, these triazole–sulfonamide–N‐hydroxycarboxamide hybrids represent promising lead molecules for further structural optimization and biological investigation.
- 17 September 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (3) , e70400
Open AccessDesign and Synthesis of Novel 1,2,3‐Triazole Conjugates Featuring Hydroxamic Acid and Sulfonamide Moieties: Exploring Dual Pharmacophores for Enhanced Biological Activity
A new series of N ‐hydroxy‐1‐(4‐(aryl sulfonamido)phenyl)‐1 H ‐1,2,3‐triazole‐4‐carboxamide derivatives ( 8a ‐ j ) were synthesized through a concise multistep route integrating three key pharmacophores: the 1,2,3‐triazole core, an aryl sulfonamide moiety, and an N ‐hydroxycarboxamide group. Biological evaluation demonstrated promising antimicrobial potential for several derivatives. Compounds 8f , 8g , and 8i exhibited notable antibacterial activity against both Gram‐positive and Gram‐negative bacteria, whereas most analogues showed weak antifungal activity. In the antimalarial assay, compound 8d emerged as the most potent derivative (IC 50 = 0.84 μg/mL), while compounds 8b , 8e , 8g , and 8h also displayed appreciable activity. Antitubercular evaluation identified compounds 8g and 8i as the most active derivatives against Mycobacterium tuberculosis H37Rv, with MIC values of 62.5 and 50 μg/mL, respectively. The molecular docking study against DNA gyrase (PDB ID: 7FVT) and lanosterol 14α‐demethylase (PDB ID: 5V5Z) as relevant antibacterial and antifungal targets, respectively, showed a similar trend of activity. Computational studies, including molecular docking, MM/GBSA, molecular dynamics simulations, and ADME prediction, supported the structural and pharmacokinetic characteristics of the synthesized compounds, with selected derivatives exhibiting favorable interactions with the c‐KIT kinase active site and generally acceptable drug‐like properties. Overall, these triazole–sulfonamide–N‐hydroxycarboxamide hybrids represent promising lead molecules for further structural optimization and biological investigation.
- Open Access
- 3 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (40) , 45379-45427
Synthesis of photoactive compounds from 2 H -pyran-2-ones and their photophysical properties
This review explored 2 H -pyran-2-ones and their derivatives as valuable building blocks for assembling different photoactive compounds. Their photophysical properties are presented.
- 3 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (40) , 45379-45427
Open AccessSynthesis of photoactive compounds from 2 H -pyran-2-ones and their photophysical properties
This review explored 2 H -pyran-2-ones and their derivatives as valuable building blocks for assembling different photoactive compounds. Their photophysical properties are presented.
- Open Access
- 28 August 2026
- Published by Elsevier in SSRN Electronic Journal
Arylsulfonyl Phenols as Potential gp120-Targeted HIV-1 Entry Inhibitors: Design, Synthesis, and Anti-HIV-1 Evaluation
The development of antiretroviral agents that disrupt the early interaction between Human immunodeficiency virus type-1 (HIV-1) and host cells offers an attractive alternative to therapies targeting viral enzymes. In this study, we evaluate arylsulfonyl phenols, a diarylsulfone subclass, as small-molecule CD4 antagonists that inhibit the envelope glycoprotein 120 (gp120) using combined in silico and in vitro approaches. Designed to occupy the hydrophobic Phe43 cavity and adjacent β20/21 region of gp120, these compounds show enhanced drug-likeness, balanced polarity, high membrane permeability, and improved predicted oral bioavailability relative to the attachment inhibitor fostemsavir. Molecular docking and MM GBSA analyses identified 5o, 5m, 5e, 5a, 5j, 4b, and 4d as high affinity compounds with favourable predicted gp120 binding scores of −7.52 to −8.26 kcal/mol and ΔGbind values of −49.71 to −56.14 kcal/mol, exceeding those of fostemsavir and the reference CD4 antagonist NBD-11021. Fifty-nanosecond molecular dynamics simulations further supported stable gp120-ligand complexes for 5o, 5m, 5a, and 5j. In vitro antiviral assays in C8166 cells demonstrated potent activity, with EC50 values of 0.0162–0.2130 μM and high therapeutic indices (TI); notably, 5a (EC50 = 0.0162 μM, TI = 162,839.51) and 5m (EC50 = 0.0238 μM, TI = 124,159.66) showed antiviral potencies approaching zidovudine (AZT). In this study, we investigated arylsulfonyl phenols, a diarylsulfone subclass, as potential small-molecule inhibitors of HIV-1 entry targeting the gp120–CD4 interaction using integrated computational and in-vitro approaches and highlight 5a and 5m as candidates for further optimization as next-generation attachment blockers.
- 28 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessArylsulfonyl Phenols as Potential gp120-Targeted HIV-1 Entry Inhibitors: Design, Synthesis, and Anti-HIV-1 Evaluation
The development of antiretroviral agents that disrupt the early interaction between Human immunodeficiency virus type-1 (HIV-1) and host cells offers an attractive alternative to therapies targeting viral enzymes. In this study, we evaluate arylsulfonyl phenols, a diarylsulfone subclass, as small-molecule CD4 antagonists that inhibit the envelope glycoprotein 120 (gp120) using combined in silico and in vitro approaches. Designed to occupy the hydrophobic Phe43 cavity and adjacent β20/21 region of gp120, these compounds show enhanced drug-likeness, balanced polarity, high membrane permeability, and improved predicted oral bioavailability relative to the attachment inhibitor fostemsavir. Molecular docking and MM GBSA analyses identified 5o, 5m, 5e, 5a, 5j, 4b, and 4d as high affinity compounds with favourable predicted gp120 binding scores of −7.52 to −8.26 kcal/mol and ΔGbind values of −49.71 to −56.14 kcal/mol, exceeding those of fostemsavir and the reference CD4 antagonist NBD-11021. Fifty-nanosecond molecular dynamics simulations further supported stable gp120-ligand complexes for 5o, 5m, 5a, and 5j. In vitro antiviral assays in C8166 cells demonstrated potent activity, with EC50 values of 0.0162–0.2130 μM and high therapeutic indices (TI); notably, 5a (EC50 = 0.0162 μM, TI = 162,839.51) and 5m (EC50 = 0.0238 μM, TI = 124,159.66) showed antiviral potencies approaching zidovudine (AZT). In this study, we investigated arylsulfonyl phenols, a diarylsulfone subclass, as potential small-molecule inhibitors of HIV-1 entry targeting the gp120–CD4 interaction using integrated computational and in-vitro approaches and highlight 5a and 5m as candidates for further optimization as next-generation attachment blockers.
- 12 November 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (44) , 10106-10117
A green and cascade synthesis of functionalized 2-aminothiophenes from ketene dithioacetals
One-pot multicomponent reactions were developed for the synthesis of tetrasubstituted aminothiophenes in water. The column chromatography-free approach was found to be useful for the synthesis of pharmaceutically active analogues.
- 12 November 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (44) , 10106-10117
A green and cascade synthesis of functionalized 2-aminothiophenes from ketene dithioacetals
One-pot multicomponent reactions were developed for the synthesis of tetrasubstituted aminothiophenes in water. The column chromatography-free approach was found to be useful for the synthesis of pharmaceutically active analogues.
- Open Access
- 16 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (16) , 12202-12245
The stereo-divergent functionalization of alkynes: a comprehensive review
Alkynes are central in crafting pharmaceuticals, agrochemicals, and materials owing to their reactivity and linear geometry. This review unveils cutting-edge advancements in the stereo-divergent functionalization of alkynes, transforming them into invaluable tools for synthesizing stereochemically defined alkenes and alkanes. The review highlights ground-breaking methodologies that achieve exceptional E- and Z-selectivity using innovative catalysts like cobalt, nickel, and palladium through hydrogenation, hydroboration, and hydrosilylation. Recent breakthroughs such as dual-catalytic systems and energy transfer catalysis enable unprecedented stereocontrol. Sustainable strategies including water as a hydrogen source and recyclable catalysts align with green chemistry principles, paving the way for eco-friendly synthesis. This synthesis of cutting-edge techniques and their applications inspire new avenues in synthetic chemistry, offering transformative tools for creating complex molecular architectures with precision and sustainability.
- 16 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (16) , 12202-12245
Open AccessThe stereo-divergent functionalization of alkynes: a comprehensive review
Alkynes are central in crafting pharmaceuticals, agrochemicals, and materials owing to their reactivity and linear geometry. This review unveils cutting-edge advancements in the stereo-divergent functionalization of alkynes, transforming them into invaluable tools for synthesizing stereochemically defined alkenes and alkanes. The review highlights ground-breaking methodologies that achieve exceptional E- and Z-selectivity using innovative catalysts like cobalt, nickel, and palladium through hydrogenation, hydroboration, and hydrosilylation. Recent breakthroughs such as dual-catalytic systems and energy transfer catalysis enable unprecedented stereocontrol. Sustainable strategies including water as a hydrogen source and recyclable catalysts align with green chemistry principles, paving the way for eco-friendly synthesis. This synthesis of cutting-edge techniques and their applications inspire new avenues in synthetic chemistry, offering transformative tools for creating complex molecular architectures with precision and sustainability.
- Open Access
- 16 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (16) , 12117-12124
A green approach towards the on-water synthesis of multifunctional 3-amino/hydroxy thieno[3,2-c]pyrans
An efficient, one-pot, and green synthesis of 3-amino/hydroxy thieno[3,2-c]pyrans was acheived from 2-oxo-2H-pyran-3-carbonitriles/carboxylates in water.
- 16 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (16) , 12117-12124
Open AccessA green approach towards the on-water synthesis of multifunctional 3-amino/hydroxy thieno[3,2-c]pyrans
An efficient, one-pot, and green synthesis of 3-amino/hydroxy thieno[3,2-c]pyrans was acheived from 2-oxo-2H-pyran-3-carbonitriles/carboxylates in water.
- 1 November 2024
- Published by Taylor & Francis in SAR and QSAR in Environmental Research
- Vol. 35 (11) , 1027-1043
Structure-based pharmacophore modelling for ErbB4-kinase inhibition: a systematic computational approach for small molecule drug discovery for breast cancer
ErbB2 kinase is a key target in approximately 20% of breast cancer cases; however, ErbB2-positive cells may shift their dependence to ErbB4 upon developing resistance to ErbB2 inhibitors. Targeting ErbB4 presents a viable strategy to address this challenge. This study employs a comprehensive approach combining structure-based pharmacophore modelling, molecular docking, and MM-GBSA calculations to identify novel ErbB4 kinase inhibitors. Critical pharmacophoric features were extracted from the crystal structures of ErbB4-lapatinib, followed by virtual screening of the Chembl database to discover potential small molecule candidates. Furthermore, the ADMET profiles of 11 shortlisted candidates were assessed to verify their pharmacokinetic and toxicity properties, identifying Chembl310724, Chembl521284, and Chembl4168686 as promising inhibitors of ErbB4 kinase activity with the binding free energy (ΔGbind) values of -99.84, -89.42 and -86.06 kcal/mol, respectively. This integrated methodology not only enhances our understanding of ErbB4 inhibition but also sets a foundation for the rational design of targeted therapies addressing breast cancer with ErbB4 dependency.
- 1 November 2024
- Published by Taylor & Francis in SAR and QSAR in Environmental Research
- Vol. 35 (11) , 1027-1043
Structure-based pharmacophore modelling for ErbB4-kinase inhibition: a systematic computational approach for small molecule drug discovery for breast cancer
ErbB2 kinase is a key target in approximately 20% of breast cancer cases; however, ErbB2-positive cells may shift their dependence to ErbB4 upon developing resistance to ErbB2 inhibitors. Targeting ErbB4 presents a viable strategy to address this challenge. This study employs a comprehensive approach combining structure-based pharmacophore modelling, molecular docking, and MM-GBSA calculations to identify novel ErbB4 kinase inhibitors. Critical pharmacophoric features were extracted from the crystal structures of ErbB4-lapatinib, followed by virtual screening of the Chembl database to discover potential small molecule candidates. Furthermore, the ADMET profiles of 11 shortlisted candidates were assessed to verify their pharmacokinetic and toxicity properties, identifying Chembl310724, Chembl521284, and Chembl4168686 as promising inhibitors of ErbB4 kinase activity with the binding free energy (ΔGbind) values of -99.84, -89.42 and -86.06 kcal/mol, respectively. This integrated methodology not only enhances our understanding of ErbB4 inhibition but also sets a foundation for the rational design of targeted therapies addressing breast cancer with ErbB4 dependency.
- 22 October 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (23) , e202400841
Thiamine (Vitamin B1) Promoted Organic Transformations: A Recent Updates
Due to the growing significance of sustainable and environmentally friendly organic transformations, there has been increasing interest in utilizing vitamins as catalysts owing to their green nature, biocompatibility, and ease of preparation. Among these, Vitamin B1, also known as thiamine stands out for its nonflammable, water‐soluble, inexpensive, and non‐toxic characteristics. This review summarized recent developments on the catalytic application of Vitamin B1 in organic transformations, particularly in facilitating C−C and C−X (N, O, S) bond formations, thus demonstrating its efficacy in synthesizing complex molecules. Vitamin B1 exhibits versatility in these reactions, functioning as both an organocatalyst as well as a co‐catalyst or ligand with other metal catalysts. The review also delves into the application of thiamine diphosphate‐dependent enzymes as catalysts in organic reactions, drawing inspiration from natural enzymatic processes. Additionally, the mechanistic intricacies of thiamine‐catalyzed reactions and the roles of co‐catalysts or additives are thoroughly examined, providing insights into reaction pathways and facilitating informed catalyst design strategies.
- 22 October 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (23) , e202400841
Thiamine (Vitamin B1) Promoted Organic Transformations: A Recent Updates
Due to the growing significance of sustainable and environmentally friendly organic transformations, there has been increasing interest in utilizing vitamins as catalysts owing to their green nature, biocompatibility, and ease of preparation. Among these, Vitamin B1, also known as thiamine stands out for its nonflammable, water‐soluble, inexpensive, and non‐toxic characteristics. This review summarized recent developments on the catalytic application of Vitamin B1 in organic transformations, particularly in facilitating C−C and C−X (N, O, S) bond formations, thus demonstrating its efficacy in synthesizing complex molecules. Vitamin B1 exhibits versatility in these reactions, functioning as both an organocatalyst as well as a co‐catalyst or ligand with other metal catalysts. The review also delves into the application of thiamine diphosphate‐dependent enzymes as catalysts in organic reactions, drawing inspiration from natural enzymatic processes. Additionally, the mechanistic intricacies of thiamine‐catalyzed reactions and the roles of co‐catalysts or additives are thoroughly examined, providing insights into reaction pathways and facilitating informed catalyst design strategies.
- Open Access
- 2 July 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Recent advancements in the synthesis of fused thienopyridines and their therapeutic applications
- 2 July 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Open AccessRecent advancements in the synthesis of fused thienopyridines and their therapeutic applications
- 5 June 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (26) , 5361-5373
Influence of steric hindrance on the 1,4- versus 1,6-Michael addition: synthesis of furans and pentasubstituted benzenes
We described the influence of steric hindrance on the 1,4- versus 1,6-Michael addition reaction on 2-(3,3-bis(methylthio)-1-arylallylidene)malononitriles.
- 5 June 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (26) , 5361-5373
Influence of steric hindrance on the 1,4- versus 1,6-Michael addition: synthesis of furans and pentasubstituted benzenes
We described the influence of steric hindrance on the 1,4- versus 1,6-Michael addition reaction on 2-(3,3-bis(methylthio)-1-arylallylidene)malononitriles.